Who
Deepika Jalota
Chief Development Officer
Company insider
Files Form 4 as: Chief Development Officer, PMV Pharmaceuticals.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $171K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 May 2021
- Last trade
- 5 Mar 2026
- Last filed
- 9 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Mar 2026filed 9 Mar 2026 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —303,310 at $0.00 | filing |
| 5 Mar 2026filed 9 Mar 2026 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —303,310 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $35K33,065 at $1.06 | filing |
| 3 Mar 2025filed 5 Mar 2025 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 11 Sep 2024filed 12 Sep 2024 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $11K7,218 at $1.50 | filing |
| 13 Aug 2024filed 3 Oct 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,674 | filing |
| 13 Aug 2024filed 3 Oct 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —68,100 | filing |
| 13 Aug 2024filed 3 Oct 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,774 | filing |
| 13 Aug 2024filed 3 Oct 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —125,000 | filing |
| 13 Aug 2024filed 3 Oct 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 | filing |
| 18 Jan 2024filed 22 Jan 2024 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —225,095 at $0.00 | filing |
| 18 Jan 2024filed 22 Jan 2024 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —95,555 at $0.00 | filing |
| 15 Sep 2023filed 18 Sep 2023 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $27K4,104 at $6.62 | filing |
| 12 May 2023filed 15 May 2023 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 9 Sep 2022filed 13 Sep 2022 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —34,050 at $0.00 | filing |
| 10 Feb 2022filed 28 Feb 2022 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —68,100 at $0.00 | filing |
| 17 Aug 2021filed 18 Aug 2021 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,896 at $0.00 | filing |
| 17 Aug 2021filed 18 Aug 2021 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $10K2,896 at $3.53 | filing |
| 17 Aug 2021filed 18 Aug 2021 | PMVP PMV PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $98K2,896 at $33.78 | filing |
| 12 May 2021filed 8 Jun 2021 | PMVP PMV Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,674 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.